Journal of bronchology & interventional pulmonology
July 1, 2026
1 min readIP Score 10/10
Endoscopic Complications Following EUS-B Fine-Needle Aspiration Performed by Interventional Pulmonologists: Incidence, Characteristics, and Prospective Cohort Analysis.
Ferreira de Almeida M; Vaz Rodrigues L; Matos P; Lourdes Barradas M; de Santis M
Abstract
BACKGROUND: To prospectively evaluate the incidence, severity, and clinical implications of esophageal mucosal injury following esophageal ultrasound using a convex EBUS bronchoscope (EUS-B-FNA). METHODS: Prospective single-center cohort of 33 adults (37 procedures) undergoing EUS-B-FNA (February to August 2025) for diagnosis or staging of pulmonary or mediastinal lesions. Postprocedure mucosa was systematically assessed by upper endoscopy or EBUS optics and classified by type, location, and extent. Complications, diagnostic yield, sample adequacy, lesion sizes, and potential risk factors were recorded. Patients were followed for 1 month. RESULTS: Mucosal alterations occurred in 89.2% (33/37) of procedures: punctate lesions (48.6%; median: 1 mm, IQR: 0.5 to 2) and edema (29.7%; median: 1 mm, IQR: 0 to 2); erythema and mild hemorrhage in 5.4% each. No ulceration, perforation, stricture, or intervention was required. Two minor events occurred (self-limited vomiting, submucosal edema). No procedure was interrupted, and no readmissions or severe events occurred during follow-up. Diagnostic yield was 59.5% and sample adequacy 86.5%. Median lesion sizes were 30 mm (IQR: 26.3 to 33.8) for intrapulmonary, 17 mm (IQR: 13 to 20) for lymphadenopathy, and 29 mm (IQR: 23.5 to 34.5) for adrenal lesions. Frequent risk factors included active malignancy (n=18) and diabetes (n=11). Median of 3 needle passes. Most procedures (89.2%) used conscious sedation. CONCLUSION: This first systematic evaluation of esophageal mucosal changes after EUS-B-FNA shows that minor alterations are common but clinically insignificant. The technique is safe, feasible, and diagnostically valuable when performed by interventional pulmonologists. Larger multicenter studies are needed to optimize risk stratification and procedural protocols.
This case highlights the diagnostic and management challenges of refractory multisystem sarcoidosis progressing over a two-year period despite advanced biologic therapy.
Clinicians should note that the presence of targetable mutations in non-small cell lung cancer with malignant pleural disease is not associated with improved survival, based on the findings from this study.
Shape-sensing robotic-assisted bronchoscopy achieved a strict diagnostic yield of 70.2% with a low pneumothorax rate of 3.3%, demonstrating that earlier tissue diagnosis of very small pulmonary nodules is feasible and safe for clinical practice.
Up nextJournal of Thoracic DiseaseOct 30, 2026Read
This study introduces ultrasound-guided trans-cannula cryobiopsy of supraclavicular lymph nodes as a novel superficial lymph node approach for tissue acquisition in 10 consecutive patients, though specific numeric success or safety results were not provided in the abstract.
Active infection is not an absolute contraindication to endobronchial valve placement, but positive pressure ventilation significantly increases clinical failure odds with an aOR of 3.00 at P < 0.001.